CTI BioPharma to Present at the Jefferies 2020 Healthcare Conference on Thursday, Jun. 4
Get Alerts CTIC Hot Sheet
Join SI Premium – FREE
SEATTLE, May 28, 2020 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ: CTIC) today announced that management will provide a corporate overview at the Jefferies 2020 Healthcare Conference at 2:30 p.m. EDT. The conference will be held in a virtual meeting format.
Presentation details: | |
Event: | Jefferies 2020 Healthcare Conference |
Date: | Thursday, Jun. 4 |
Time: | 2:30 p.m. EDT |
The presentation will be webcast live and available for replay from the Investors section of CTI BioPharma's website at www.ctibiopharma.com.
About CTI BioPharma Corp.
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on evaluating pacritinib, our sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. We are headquartered in Seattle, Washington.
CTI BioPharma Investor Contacts:
Argot Partners Maeve Conneighton/Maghan Meyers +1-212-600-1902[email protected]
View original content to download multimedia:http://www.prnewswire.com/news-releases/cti-biopharma-to-present-at-the-jefferies-2020-healthcare-conference-on-thursday-jun-4-301066429.html
SOURCE CTI BioPharma Corp.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stax Appoints Andrew Keller to Oversee Technology Market Coverage for U.K. and EMEA
- PeriodCute's New Store Grand Opening, Providing You With Efficient, High Quality and Beneficial Beauty
- Bioforum the Data Masters Introduces SUBMIT24: A Free of Charge and Revolutionary CDISC CORE-Based Clinical Data Validation Tool
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Jefferies & Co, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!